Novel approach to targeted protein degradation, Nicki Thompson, CEO, Amphista Therapeutics
Biotech 2050 Podcast
00:00
Targeted Protein Degradation - What Are You Really Excited About?
What I'm really excited about is fundamentally I think targeted protein degradation meets an enormous unmet need. It's a space that over the last five to ten years has moved quite rapidly through to the clinic with those first approaches and they're generally focused in the oncology space. What excites me about what we're able to do is because we are engaging parts of the machinery that are broadly expressed that means that we can be effective in a much broader range of cells and tissues even within patient groups.
Transcript
Play full episode
